// App-Quantinova.ai

SCI-39 : Selecting T-Cell Subsets for Adoptive T-Cell Therapy to Optimize Potency and Persistence

Researchers

Presenter

  • Stanley Riddell

Principal Investigators

  • Cameron J Turtle

  • Michael Hudecek

  • Daniel Sommermeyer

  • Michael C Jensen

Medical Centers

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Fred Hutchinson Cancer Resaerch Center, Seattle, WA

  • Department of Radiology, University of Washington, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Refractory malignancies

  • B cell lymphomas

  • Lymphomas

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Coxsackie Virus And Adenovirus Receptor

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved